Chiron Investment Management, LLC Biogen Inc. Transaction History

Chiron Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $23.7 Million - $33.5 Million	-91,096 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $9.57 Million - $10.7 Million	31,100 Added 51.84%	91,096 $29 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $8.71 Million - $10.2 Million	30,996 Added 106.88%	59,996 $18.8 Million
Q2 2017 Aug 15, 2017	BUY	N/A	29,000	29,000 $7.87 Million

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.